Shumway N E, Stinson E B, Oyer P E, Jamieson S W, Baldwin J C
Schweiz Med Wochenschr. 1985 Nov 9;115(45):1571-4.
Twenty-seven years of laboratory experience in cardiac transplantation at Stanford have provided the necessary background for a moderately successful clinical program which now extends over a period of 17 years. Heart-lung transplantation, again entirely a product of intensive laboratory research, is now ready for clinical use. Certainly much work remains to be done in the area of donor tissue preservation, particularly with respect to the lungs. It appears that new and more specific immunosuppressing drugs are on the horizon, so tissue transplantation in general will be increasingly safer. Heart transplantation has come of age, and combined heart-lung transplantation is well under way.
斯坦福大学27年的心脏移植实验室经验为一个较为成功的临床项目提供了必要的背景，该临床项目目前已延续了17年。心肺移植同样完全是深入实验室研究的成果，现已准备好用于临床。当然，在供体组织保存领域，尤其是肺部方面，仍有许多工作要做。看来新的、更具特异性的免疫抑制药物即将出现，因此总体而言组织移植将越来越安全。心脏移植已步入成熟阶段，心肺联合移植也在顺利进行。
